Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis.
Wan-Hsuan HsuBo-Wen ShiauTing-Hui LiuJheng-Yen WuYa-Wen TsaiPo-Yu HuangMin-Hsiang ChuangChih-Cheng LaiChi-Hsing ChenPublished in: Expert review of anti-infective therapy (2023)
NMV-rcan reduce all-cause hospitalization and mortality among patients with LC who have COVID-19.